Immix Biopharma, Inc. (NASDAQ:IMMX) ImmixBio Approves 4 Additional Clinical Trial Sites for IMX-110 Clinical Trials, Complementing Existing Soft Tissue Sarcoma Lead Site California Soft Tissue ...

The Investor Movement Index® (IMXSM) increased to 4.74 in April, up from its score of 4.57 in March. The IMX is TD Ameritrade’s proprietary, behavior- ...